These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18533725)

  • 1. Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein.
    Andrianov AM
    J Biomol Struct Dyn; 2008 Aug; 26(1):49-56. PubMed ID: 18533725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophilins and HIV-1 V3 loop for structure-based anti-AIDS drug design.
    Andrianov AM
    J Biomol Struct Dyn; 2009 Feb; 26(4):445-54. PubMed ID: 19108583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
    Andrianov AM; Anishchenko IV
    J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
    Andrianov AM; Veresov VG
    J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local structural properties of the V3 loop of Thailand HIV-1 isolate.
    Andrianov AM
    J Biomol Struct Dyn; 2002 Jun; 19(6):973-89. PubMed ID: 12023800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational preferences of the HIV-1 principal neutralizing determinant.
    Andrianov AM
    J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].
    Andrianov AM
    Tsitologiia; 2006; 48(11):948-57. PubMed ID: 17233480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the V3 loop of a Thailand HIV isolate.
    Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
    J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood.
    Endrich MM; Gehring H
    Eur J Biochem; 1998 Mar; 252(3):441-6. PubMed ID: 9546659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel promising targets for anti-AIDS drug developments by computer modeling: application to the HIV-1 gp120 V3 loop.
    Andrianov AM; Anishchenko IV; Tuzikov AV
    J Chem Inf Model; 2011 Oct; 51(10):2760-7. PubMed ID: 21888425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
    J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
    Weliky DP; Bennett AE; Zvi A; Anglister J; Steinbach PJ; Tycko R
    Nat Struct Biol; 1999 Feb; 6(2):141-5. PubMed ID: 10048925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic NMR studies of ligand-receptor interactions: design and analysis of a rapidly exchanging complex of FKBP-12/FK506 with a 24 kDa calcineurin fragment.
    Fejzo J; Lepre CA; Peng JW; Su MS; Thomson JA; Moore JM
    Protein Sci; 1996 Sep; 5(9):1917-21. PubMed ID: 8880916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.
    Andrianov AM
    J Biomol Struct Dyn; 2008 Oct; 26(2):247-54. PubMed ID: 18597546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.